Immune Analytics as specialist CRO offers immunomonitoring services with a strong focus on the analysis of preclinical and clinical samples by EliSpot (enzyme-linked immuno spot) or FluoroSpot supported by a range of other methods like ELISA, flow cytometry and immune arrays. With a dedicated team of scientists, project manager and QA colleagues, Immune Analytics is specialized in the realization of projects with a high degree of assay customization.
Besides the excellent scientific and technical competence, Immune Analytics adheres to international regulatory requirements of preclinical and clinical studies and is certified according to Good Laboratory Practice (GLP) and Good Clinical Laboratory Practice (GCLP).
Immune Analytics also offers competent support for your research and development projects in the field of immunology.
Immune Analytics is backed by the longstanding experience of the AID group in development and manufacturing of EliSpot kits, readers and analysis software. Offices and laboratories are located on the premises of the AID headquarters in the Strassberg, Germany.

The pillars of our quality management system to support your drug studies are:

- GLP & GCLP*-compliance of all procedures carried out in our service laboratory
- Highly trained, skilled and experienced personnel
- Highest patient safety by consistent sample management and maximum data integrity
- Extensive assay validation and peer-review for all (experimental) procedures
- GxP compliant documentation from sample receipt via reporting and data transfer to archiving
- Application of validated computerized systems
- Internal quality assurance by regular monitoring of all laboratory procedures (SOPs) by QA personnel
- Implemented risk management
- Change and deviation management (CAPA)
- Open, efficient and solution-oriented communication with our customers

We´re looking forward to your requests! www.immune-analytics.com

+ SARS-CoV-2 ++++

NOTE: We have developed COVID19 / SARS-CoV2 EliSpot and FluoroSpot assays to support vaccine development projects! We have also developed in vitro culture conditions to evaluate memory T cells against SARS-CoV-2 in EliSpot/FluoroSpot. Please contact us for further details!

---

*EMA Reflection paper for laboratories that perform the analysis
or evaluation of clinical trial samples 28 February 2012
EMA/INS/GCP/532137/2010:
http://www.ema.europa.eu/docs/en_GB/document_library/Reg
ulatory_and_procedural_guideline/2012/05/WC500127124.pdf